ProfileGDS4459 / ENSG00000169202
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 50% 23% 38% 41% 46% 31% 26% 29% 41% 37% 32% 32% 34% 30% 30% 56% 4% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.4250
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.5123
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 33.8738
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.2141
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.2446
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 63.7131
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 73.3726
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.4929
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 94.0141
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 103.937
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.6732
GSM623475group B, liver allograft wedge biopsie placebo treatment 23.6232
GSM623476group B, liver allograft wedge biopsie placebo treatment 33.834
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.7930
GSM623478group B, liver allograft wedge biopsie placebo treatment 53.5230
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.5956
GSM623480group B, liver allograft wedge biopsie placebo treatment 72.54